Manju L Prasad
Overview
Explore the profile of Manju L Prasad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
2206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Diagnostically Challenging Case: Metastatic Hepatocellular Carcinoma With No Liver Lesion at Imaging
Zambrano A, Quesada J, Torres A, Escobar J, Prasad M, Renjifo M, et al.
J Glob Oncol
. 2018 Sep;
4:1-5.
PMID: 30241223
No abstract available.
22.
Delgado S, Smith S, Mehra S, Prasad M
Int J Surg Pathol
. 2018 Sep;
27(3):282-289.
PMID: 30222023
Composite paragangliomas are rare with less than 20 cases documented in the abdomen, retroperitoneum, and urinary bladder. In this article, we report the first case of composite paraganglioma in the...
23.
Morse E, Fujiwara R, Judson B, Prasad M, Mehra S
Laryngoscope
. 2018 Sep;
129(1):129-137.
PMID: 30194762
Objectives/hypothesis: To establish benchmarks for positive margin incidence in parotid cancers, associate positive margin status with patient, tumor, and institutional factors and overall survival, and characterize institutional variation in positive...
24.
Nicolson N, Murtha T, Dong W, Paulsson J, Choi J, Barbieri A, et al.
J Clin Endocrinol Metab
. 2018 May;
103(7):2640-2650.
PMID: 29726952
Context: Follicular thyroid carcinoma (FTC) is classified into minimally invasive (miFTC), encapsulated angioinvasive (eaFTC), and widely invasive (wiFTC) subtypes, according to the 2017 World Health Organization guidelines. The genetic signatures...
25.
Rubinstein J, Majumdar S, Laskin W, Lazaga F, Prasad M, Carling T, et al.
J Endocr Soc
. 2017 Dec;
1(7):926-930.
PMID: 29264543
Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is a rare autosomal dominant cause of familial hyperparathyroidism associated with benign, ossifying fibromas of the maxillofacial bones and increased risk of parathyroid carcinoma. The putative...
26.
Chandler J, Colunga M, Prasad M, Callender G, Quinn C, Chhieng D, et al.
Cancer Cytopathol
. 2017 Aug;
125(11):865-875.
PMID: 28834409
Background: A major reclassification occurred with the redesignation of noninvasive encapsulated follicular variant of papillary thyroid carcinoma as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) due to its...
27.
Xu B, Scognamiglio T, Cohen P, Prasad M, Hasanovic A, Tuttle R, et al.
Hum Pathol
. 2017 May;
65:133-139.
PMID: 28552827
Metastatic papillary thyroid carcinoma (PTC) without an identifiable primary tumor despite extensive microscopic examination of the thyroid gland is a rare but true phenomenon.We retrieved 7 of such cases and...
28.
Hardee S, Prasad M, Hui P, Dinauer C, Morotti R
Pediatr Dev Pathol
. 2017 May;
20(3):206-212.
PMID: 28521635
The BRAF mutation is the most common genetic aberration in papillary thyroid cancer (PTC), found in up to 68% of PTC in adults where it is associated with aggressive features....
29.
Panaccione A, Zhang Y, Mi Y, Mitani Y, Yan G, Prasad M, et al.
Oral Oncol
. 2017 Mar;
66:38-45.
PMID: 28249646
Background: Mucinous adenocarcinoma of the salivary gland (MAC) is a lethal cancer with unknown molecular etiology and a high propensity to lymph node metastasis. Mostly due to its orphan status,...
30.
Cheng J, Brown T, Murtha T, Stenman A, Juhlin C, Larsson C, et al.
BMC Cancer
. 2017 Mar;
17(1):164.
PMID: 28249601
Background: Dysregulated WNT signaling dominates adrenocortical malignancies. This study investigates whether silencing of the WNT negative regulator DKK3 (Dickkopf-related protein 3), an implicated adrenocortical differentiation marker and an established tumor...